Product Safety Recalls

Product Recall Tracker

TIMOLOL Recall D-1471-2022

Description: Timolol Maleate Ophthalmic Solution, USP, 0.5%, 5 x 0.3 mL Single-Dose Vials, Rx Only, Sterile, Manufactured for: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-189-24

TIMOLOL Recall D-1471-2022 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-1471-2022
Event ID90720
BrandTIMOLOL MALEATE
Generic NameTIMOLOL
ManufacturerTIMOLOL
Original Package?1
Active SubstanceTIMOLOL
Drug RouteOPHTHALMIC
DistributionDistributed Nationwide in the USA
Quantity5,226 Cartons (60 vials/carton)
Recall ReasonIdentification of an unknown impurity at the 12-month stability point. Further investigation has identified the impurity as Timolol Phenol S-Oxide.
Drug ClassificationClass III
Drug Code Info20220907
Product NDC17478-189
Recall Initiation Date20220808
Report Date20220907
Classification Date20220829
Address5605 Centerpoint Ct Ste B
Gurnee, IL 60031-5278
United States
Recalling FirmAkorn, Inc
Initial Notification Letter
Unique Ingredient Identifier817W3C6175
Drug Application NumberANDA212291
Structured Product Labeling (SPL ID)54f834c6-e4fc-477a-aeb8-426de2590232
Structured Product Labeling (SPL Set ID)b969bb47-6b4a-46ee-93cc-52faee4369c4
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.